Group Total P-value Between 2nd and 3rd doses P-value After 3rd dose P-value
Controls 80 80 30
28 (35%) 13 (16.3%) 15 (50%)
AIIRD patients 124 124 64
59 (47.6) 0.1033 33 (26.6%) 0.1193 26 (40.6%) 0.5278
JIA 54 54 23
26 (48.2) 0.1794 17 (31.5%) 0.0624 9 (39.1%) 0.6104
SLE 20 20 10
7 (35%) 1 3 (15%) 1 4 (40%) 0.855